Clinical Trial

Real World Evidence Solutions Market worth $10.83 billion by 2030 with 14.8% CAGR | MarketsandMarkets™

DELRAY BEACH, Fla., Aug. 19, 2025 /PRNewswire/ -- The global Real World Evidence Solutions Market, valued at US$4.74 billion in 2024,…

4 months ago

Qaelon Medical Announces Formation of Scientific Advisory Board and Appoints Dr. Andrew Storm

STRASBOURG, France, Aug. 19, 2025 /PRNewswire/ -- Qaelon Medical, a pioneer in real-time surgical leak detection and advanced insufflation technology,…

4 months ago

LabConnect Launches LabConnector™ to Streamline Lab Data Integration

New service ensures faster, more accurate data delivery to clients JOHNSON CITY, Tenn., Aug. 19, 2025 /PRNewswire/ -- LabConnect, LLC,…

4 months ago

University Hospitals Launches HealthSnap-Powered RPM for Uncontrolled Hypertension Care

CLEVELAND and MIAMI, Aug. 19, 2025 /PRNewswire/ -- HealthSnap, a leading virtual care management company, announced today that University Hospitals (UH),…

4 months ago

New US$ 1 Million Prize Competition Aims to Revolutionize Alzheimer’s Research by Leveraging Agentic AI Systems

SEATTLE, Aug. 19, 2025 /PRNewswire/ -- The Alzheimer's Disease Data Initiative (AD Data Initiative) today launched the Alzheimer's Insights AI Prize |…

4 months ago

Ensysce Biosciences’ Geoff Birkett to Chair the Fierce New Product Planning Summit 2025

~ The Summit is the Premier Industry Event for Defining How New Product Planning Teams and Related Functions Make Informed,…

4 months ago

Zomedica and VerticalVet Announce Strategic Partnership to Deliver Advanced Veterinary Technologies to Independent Practices

New agreement brings innovative shock wave, tPEMF therapy, monitoring, and bleeding control solutions to more than 2,200 member clinics nationwide…

4 months ago

Kyowa Kirin Premiers New CTCL Staging Tool for Healthcare Providers

First-of-its kind tool to guide HCPs on what to consider when staging patients with Mycosis Fungoides and Sézary SyndromePRINCETON, N.J.,…

4 months ago

60 Degrees Pharmaceuticals Selects Icahn School of Medicine at Mount Sinai as Central Clinical Trial Site for Phase II Study to Evaluate Tafenoquine for Chronic Babesiosis

90-day trial measuring change in general fatigue in chronic babesiosis patientsEnrollment expected to commence Q4 2025 and to be completed…

4 months ago